Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (81-90 of 525) with videos related to

Pageof 53
Sort By:
Brain Pathology (Zurich, Switzerland)|May 19, 2010
Fixation of brain tumor biopsy specimens with RCL2 results in well-preserved histomorphology, immunohistochemistry and nucleic acidsMatthias Preusser, Sabina Plumer, Elisabeth Dirnberger, et al.
Neuro-Oncology|December 9, 2023
The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH-mutant gliomasNathalie L Albert, Julia Furtner, Martin J van den Bent, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 21, 2007
Papillary glioneuronal tumorEllen Gelpi, Matthias Preusser, Thomas Czech, et al.
Journal of Neuro-Oncology|May 22, 2012
Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysisPeter Horak, Adelheid Wöhrer, Marco Hassler, et al.
Translational Oncology|February 21, 2012
Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical gradeSandra Sampl, Sibylle Pramhas, Christian Stern, et al.
Anti-Cancer Drugs|February 26, 2015
Breast cancer brain metastases responding to lapatinib plus capecitabine as second-line primary systemic therapyElisabeth S Bergen, Anna S Berghoff, Margaretha Rudas, et al.
ESMO Open|July 13, 2019
How we treat glioblastomaMichael Weller, Emilie Le Rhun, Matthias Preusser, et al.
ESMO Open|December 5, 2019
CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an <i>ESMO Open-Cancer Horizons</i> pro and con discussionAhmad Awada, Joseph Gligorov, Guy Jerusalem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Myxopapillary ependymoma with pleuropulmonary metastases and high plasma glial fibrillary acidic protein levelsAysegül Ilhan, Julia Furtner, Peter Birner, et al.
Current Opinion in Neurology|October 31, 2012
Brain metastasis: opportunity for drug development?Matthias Preusser, Anna S Berghoff, Dirk Schadendorf, et al.
Pageof 53

Showing results (81-90 of 525) with videos related to

Sort By:
Pageof 53
Brain Pathology (Zurich, Switzerland)|May 19, 2010
Fixation of brain tumor biopsy specimens with RCL2 results in well-preserved histomorphology, immunohistochemistry and nucleic acidsMatthias Preusser, Sabina Plumer, Elisabeth Dirnberger, et al.
Neuro-Oncology|December 9, 2023
The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH-mutant gliomasNathalie L Albert, Julia Furtner, Martin J van den Bent, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 21, 2007
Papillary glioneuronal tumorEllen Gelpi, Matthias Preusser, Thomas Czech, et al.
Journal of Neuro-Oncology|May 22, 2012
Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysisPeter Horak, Adelheid Wöhrer, Marco Hassler, et al.
Translational Oncology|February 21, 2012
Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical gradeSandra Sampl, Sibylle Pramhas, Christian Stern, et al.
Anti-Cancer Drugs|February 26, 2015
Breast cancer brain metastases responding to lapatinib plus capecitabine as second-line primary systemic therapyElisabeth S Bergen, Anna S Berghoff, Margaretha Rudas, et al.
ESMO Open|July 13, 2019
How we treat glioblastomaMichael Weller, Emilie Le Rhun, Matthias Preusser, et al.
ESMO Open|December 5, 2019
CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an <i>ESMO Open-Cancer Horizons</i> pro and con discussionAhmad Awada, Joseph Gligorov, Guy Jerusalem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Myxopapillary ependymoma with pleuropulmonary metastases and high plasma glial fibrillary acidic protein levelsAysegül Ilhan, Julia Furtner, Peter Birner, et al.
Current Opinion in Neurology|October 31, 2012
Brain metastasis: opportunity for drug development?Matthias Preusser, Anna S Berghoff, Dirk Schadendorf, et al.
Pageof 53